Improving Delivery and Efficacy of Nanomedicines in Solid Tumors: Role of Tumor Priming
Year: 2011
Type: review
Abstract: Effectiveness of nanomedicines in cancer therapy is limited in part by inadequate delivery and transport in tumor interstitium. This article reviews the experimental approaches to improve nanomedicine delivery and transport in solid tumors. These approaches include tumor vasculature normalization, interstitial fluid pressure modulation, enzymatic extracellular matrix degradation, and apoptosis-inducing tumor priming technology. We advocate the latter approach due to its ease and practicality (accomplished with standard-of-care chemotherapy, such as paclitaxel) and tumor selectivity. Examples of applying tumor priming to deliver nanomedicines and to design drug/RNAi-loaded carriers are discussed.
Source: Nanomedicine
DOI: 10.2217/nnm.11.141
Institution: The Ohio State University
Language: English
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Open Access status: green
Awards: Synergistic chemo-siRNA combination therapy, rTS Signaling Mimetics As Novel Cancer Therapeutics, Apoptosis Inducing to Enhance Tumor Targeting, Capturing dynamic and inter-dependent biointerfaces in nanotechnology designs, Develop a Primary Care Colon Cancer Screening Consortium, Intraperitoneal Tumor-Targeting Chemo-gene Therapy, TARGETING THE CASM ONCOGENE AS A NOVEL THERAPY FOR PANCREATIC CANCER
OpenAlex ID: W1967389270
